Company Analysis

Aclarion, Inc. (ACON)

Nasdaq: ACON · Services-Medical Laboratories · Broomfield, CO · filing with the SEC since 2015
Grade3.5
◀ Past 1.2● Present 2.8▶ Future 6.8
2 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

20 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Aclarion, Inc.’s names, not what it holds today.

Patents granted
20
20 utility, 1976 to Dec 31, 2025
Granted in 2025
2
Against 1 in 2024 and 3 in 2023
Applications published
22
2 of them in 2025
Names they are printed under
4
a former name, its own name
By yearGrantedApplications published
'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Medical technology5
Measurement2
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
NociMed, Inc. a former name
US, as the owner printed on each patent
14 granted
2 published
NOCIMED, INC. a former name
named as the applicant on its applications, in US
0 granted
13 published
ACLARION, INC. its own name
named as the applicant on its applications, in US
0 granted
7 published
Aclarion, Inc. its own name
US, as the owner printed on each patent
6 granted
0 published
Newest grantseach row opens the USPTO’s own copy
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Oct 16, 20252025/0318775MAGNETIC RESONANCE SPECTROSCOPY SYSTEM AND METHOD FOR DIAGNOSING PAIN OR INFECTION ASSOCIATED WITH PROPIONIC ACIDMeasurementACLARION, INC.
Mar 27, 20252025/0098976MAGNETIC RESONANCE SPECTROSCOPY PULSE SEQUENCE, ACQUISITION, AND PROCESSING SYSTEM AND METHODMedical technologyACLARION, INC.
Dec 28, 20232023/0414126MAGNETIC RESONANCE SPECTROSCOPY PULSE SEQUENCE, ACQUISITION, AND PROCESSING SYSTEM AND METHODMedical technologyACLARION, INC. · patent 12,097,020 granted from it
Nov 9, 20232023/0355167MAGNETIC RESONANCE SPECTROSCOPY SYSTEM AND METHOD FOR DIAGNOSING PAIN OR INFECTION ASSOCIATED WITH PROPIONIC ACIDMeasurementACLARION, INC. · patent 12,239,455 granted from it
May 4, 20232023/0140742SYSTEM FOR MACHINE LEARNING-BASED MODEL TRAINING AND PREDICTION FOR EVALUATION OF PAINMedical technologyACLARION, INC.
Oct 13, 20222022/0322957MAGNETIC RESONANCE SPECTROSCOPY PULSE SEQUENCE, ACQUISITION, AND PROCESSING SYSTEM AND METHODMedical technologyACLARION, INC. · patent 11,633,124 granted from it
Jun 9, 20222022/0175264MR SPECTROSCOPY SYSTEM AND METHOD FOR DIAGNOSING PAINFUL AND NON-PAINFUL INTERVERTEBRAL DISCSMedical technologyACLARION, INC. · patent 11,844,601 granted from it
Feb 25, 20212021/0052185MAGNETIC RESONANCE SPECTROSCOPY PULSE SEQUENCE, ACQUISITION, AND PROCESSING SYSTEM AND METHODMedical technologyNOCIMED, INC. · patent 11,179,057 granted from it
Apr 2, 20202020/0100698MR SPECTROSCOPY SYSTEM AND METHOD FOR DIAGNOSING PAINFUL AND NON-PAINFUL INTERVERTEBRAL DISCSMedical technologyNOCIMED, INC.
Oct 10, 20192019/0307393MAGNETIC RESONANCE SPECTROSCOPY SYSTEM AND METHOD FOR DIAGNOSING PAIN OR INFECTION ASSOCIATED WITH PROPIONIC ACIDMeasurementNOCIMED, INC. · patent 11,564,619 granted from it
What it applied for, 2024 to 2025: Medical technology 1 · Measurement 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton ACON · research, not advice